Searched for
PHARMACEUTICAL ACQUISITIONS
RPG Life Sciences to deploy Rs 500 crore in next 12 months to bolster manufacturing, API capabilitiesRPG Life Sciences plans to deploy Rs 500 crore over the next 12 months to expand manufacturing and API capabilities through strategic acqui...- Novartis India to pursue therapy-aligned acquisitions; eyes expansion in Tier 2 and Tier 3 marketsNovartis India plans acquisitions and deeper market penetration for future growth. The company will focus on five key therapy areas for exp...
- Adobe’s next boss joins a powerful club: Meet the Indian-origin CEOs running the world’s biggest companiesAdobe’s next CEO Anil Chakravarthy is joining a powerful club. From Microsoft and Google to Chanel, FedEx and Micron, Indian-origin executi...
- RPG Life Sciences subsidiary acquires Raghava Life Sciences' API biz for Rs 135 crRPG Active Pharma is acquiring Raghava Life Sciences' API and intermediates business. This strategic move aims to strengthen its integrated...
- Sun Pharma agrees to lower US drug prices under Trump plan; analysts see limited financial impactSun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affor...
- Permira to buy 25.71% in Cloudnine Hospitals parent: CCI filingPermira, a leading global private equity firm, is ready to buy a significant stake in Cloudnine Hospitals, which places the parent company'...
- Sun Pharma to extend MFN pricing to US state Medicaid programmesSun Pharma ranks second in US dermatology by prescriptions, with key brands including Ilumya for plaque psoriasis and Winlevi for acne. Rec...
- Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targetsElara has initiated coverage on four pharmaceutical stocks, assigning Buy, Accumulate and Reduce ratings. Alkem Laboratories emerged as its...
- Yatharth Hospitals draws interest from Aster, Advent as healthcare consolidation heats upAster DM Quality Care is negotiating to acquire a controlling stake in Yatharth Hospitals. This potential acquisition aims to consolidate t...
- US envoy Sergio Gor meets Piramal Group Chairman Ajay Piramal, discusses expansion plans in USUS Ambassador Sergio Gor met Piramal Group Chairman Ajay Piramal discussing economic ties. Gor lauded Piramal's growing United States footp...
- Indian companies step up acquisitions for AI, technology and talent: CrisilThe ratings agency said mergers and acquisitions are evolving from an occasional growth option into a core strategic tool for companies see...
- Entero Healthcare shares gain 15% in 2 days after Prashant Jain’s 3P Investment picks stake in block dealEntero Healthcare Solutions shares rose sharply after Prashant Jain-owned 3P Investment Managers acquired a 2.5% stake in the company throu...
- Before Xi Jinping's likely India visit, Chinese money is pouring inIndia is cautiously reopening economic channels with China as Chinese linked investment returns after years of restrictions following the G...
- Kronox Lab Sciences shares rally 32% in 2 days as Indo Borax, Zenrock Chemicals eye stake acquisitionShares of Kronox Lab Sciences surged after Indo Borax and Zenrock Chemicals announced plans to acquire a 64.26% stake in the company and la...
- Horizon Industrial Parks IPO Day 3: Subscription hits 1.45x. Check GMP and other key detailsHorizon Industrial Parks IPO GMP Today: Horizon Industrial Parks IPO enters its final bidding day with 24% subscription after Day 2 and a m...
- Horizon Industrial Parks IPO Day 2: GMP, subscription status and key details; should you subscribe?Horizon Industrial Parks IPO entered its second day of bidding with a 14% subscription on Day 1. Backed by Blackstone, the Rs 2,600 crore i...
- Gland Pharma appoints Dr Reddy’s senior executive Deepak Sapra as CEOGland Pharma has appointed Deepak Sapra as its new chief executive officer, with his tenure set to begin on November 16, 2026, subject to h...
- Marksans Pharma shares rally over 9% after Q1 profit spikes 174% YoY to Rs 159 croreMarksans Pharma shares surged after Q1FY27 profit jumped 174% YoY to Rs 159 crore. Revenue rose 35.6% to Rs 841 crore, while EBITDA hit a r...
- Warburg set to buy Seacod-maker Universal NutriScience for Rs 2800 croreWill be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.
- Emcure Pharma net profit up 36% at Rs 292 croreEmcure Pharmaceuticals reported a 23% revenue increase in the first quarter. Ebitda grew 25.8% with improved margins, reflecting productivi...
Load More
